Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
If your insurance has coverage for weight loss, you should consult with your primary care physician for treatment
Additionally, DSIP appears to be regulated by glucocorticoids, and its signaling may interact with the MAPK cascade through homology with glucocorticoid-induced leucine zipper (GILZ), suggesting potential roles in cellular stress responses
Medications Available Through MEDVi MEDVi prescribes compounded versions of the two dominant GLP-1 weight loss drugs: semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound)
By integrating semaglutide GLP-1 into our range of services, we continue to lead in offering personalized, cutting-edge treatments that help our patients achieve their desired health and aesthetic outcomes
